Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment

N Duma, R Santana-Davila, JR Molina - Mayo Clinic Proceedings, 2019 - Elsevier
Lung cancer remains the leading cause of cancer deaths in the United States. In the past
decade, significant advances have been made in the science of non–small cell lung cancer …

Risk factors for lung cancer worldwide

J Malhotra, M Malvezzi, E Negri… - European …, 2016 - Eur Respiratory Soc
Lung cancer is the most frequent malignant neoplasm in most countries, and the main
cancer-related cause of mortality worldwide in both sexes combined. The geographic and …

[HTML][HTML] Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

J Ferlay, E Steliarova-Foucher, J Lortet-Tieulent… - European journal of …, 2013 - Elsevier
INTRODUCTION: Cancer incidence and mortality estimates for 25 cancers are presented for
the 40 countries in the four United Nations-defined areas of Europe and for the European …

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M Reck, S Popat, N Reinmuth… - Annals of …, 2014 - annalsofoncology.org
Primary lung cancer is the most common malignancy after nonmelanocytic skin cancer with
deaths from lung cancer exceeding those from any other type of malignancy worldwide [1] …

[HTML][HTML] European cancer mortality predictions for the year 2014

M Malvezzi, P Bertuccio, F Levi, C La Vecchia… - Annals of oncology, 2014 - Elsevier
Background From most recent available data, we projected cancer mortality statistics for
2014, for the European Union (EU) and its six more populous countries. Specific attention …

A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs

A Carrato, A Falcone, M Ducreux, JW Valle… - Journal of …, 2015 - Springer
Purpose The purpose of this study was to assess the overall burden of pancreatic cancer in
Europe, with a focus on survival time in a real-world setting, and the overall healthy life lost …

Pancreatic adenocarcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

T Seufferlein, JB Bachet, E Van Cutsem… - Annals of …, 2012 - annalsofoncology.org
In Europe, cancer of the pancreas is the seventh most frequent cancer, accounting for some
2.8% of cancer in men and 3.2% in women. It is the fifth leading cause of cancer-related …

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

S Peters, AA Adjei, C Gridelli, M Reck… - Annals of …, 2012 - annalsofoncology.org
Primary lung cancer is the most common malignancy after non-melanocytic skin cancer, and
the leading cause of human cancer deaths worldwide [1]. While it has been the most …

[HTML][HTML] European cancer mortality predictions for the year 2016 with focus on leukaemias

M Malvezzi, G Carioli, P Bertuccio, T Rosso, P Boffetta… - Annals of …, 2016 - Elsevier
Background Current cancer mortality statistics are important for public health decision-
making and resource allocation. Age-standardized rates and numbers of deaths are …

[HTML][HTML] European cancer mortality predictions for the year 2013

M Malvezzi, P Bertuccio, F Levi, C La Vecchia… - Annals of oncology, 2013 - Elsevier
Background Estimated cancer mortality statistics were published for the years 2011 and
2012 for the European Union (EU) and its six more populous countries. Patients and …